Psilocybin trial reveals drug's efficacy in treating serious depression

Brasil Notícia Notícia

Psilocybin trial reveals drug's efficacy in treating serious depression
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 59%

The largest-ever study of the psychedelic drug psilocybin revealed that the drug is effective in treating serious depression.

The largest-ever study of the psychedelic drug psilocybin revealed Tuesday that the drug is effective in treating serious depression,The Compass Pathways study, which is the "largest randomized, controlled, double-blind trial of psilocybin," found that patients who were given the highest dose of the drug had a significant decrease in depressive symptoms as compared to the placebo group, per Stat.Subscribe for freeAbout 29.

The patients that received 25-milligram — the highest dose of the drug in the study — also experienced a "highly statistically significant and clinically relevant reduction in depressive symptom severity after three weeks," per Compass Pathways. Patients who received the lower 10-milligram dose did not experience a statistically significant difference after three weeks.The results of the study, which included 233 patients across Europe and North America, come after the Food and Drug Administration granted Compass Pathways a breakthrough therapy designation, paving the way for a potentially accelerated drug approval process, per Stat.The study also included data on patients who experienced adverse side effects from the drug.

Twelve patients reported treatment-emergent serious adverse events, including five who were in the 25-milligram group and six in the 10-milligram group. "The suicidal behaviors were reported at least one month after the administration of treatment and they occurred in patients who were essentially non-responding," Guy Goodwin, Compass’ chief medical officer, said Tuesday, per Stat.The results have not been published in a medical journal or peer-reviewed, according to Stat.Compass is in the early stages of beginning a Phase 3 trial next year, per Stat.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

YahooNews /  🏆 380. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Covid: Medication holiday may boost vaccine protectionCovid: Medication holiday may boost vaccine protectionA trial will look at how to protect patients against Covid who also need immunosuppressant drugs.
Consulte Mais informação »

Kyle Rittenhouse Judge Shouts Out Veterans in Court, Debatably Influences CaseKyle Rittenhouse Judge Shouts Out Veterans in Court, Debatably Influences CaseThe judge in the Kyle Rittenhouse trial did something that, on its face, seems pure and patriotic -- but, arguably it could also, unjustly, impact the outcome of the trial.
Consulte Mais informação »

7 Derm-Approved Tips for Clearing Up Painful Cystic Breakouts7 Derm-Approved Tips for Clearing Up Painful Cystic BreakoutsThese are the most effective ways to treat cystic acne without a cortisone shot.
Consulte Mais informação »

The Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe Is On Major Sale at Best Buy
Consulte Mais informação »

The Fitbit Luxe is on Major Sale Right NowThe Fitbit Luxe is on Major Sale Right NowTreat yourself to an early Christmas gift.
Consulte Mais informação »



Render Time: 2025-03-07 02:27:00